Biotechs, generic-drug makers and ethical-drug makers are some of the highest-ranked industry groups among the 197 that IBD tracks, and with recent view-topping earnings reports, FDA approvals and strategic divestments, they’re proving their strength. Five hot drug stocks lead IBD’s Screen Of The Day, Big Cap Leaders: Gilead Sciences (GILD), Jazz Pharmaceuticals (JAZZ), Allergan (AGN), Regeneron Pharmaceuticals (REGN) and Mallinckrodt (MNK).
Earnings season has kicked into high gear, and a number of top-rated stocks such as Vasco Data Security (VDSI) and Facebook (FB) are due to report earnings this coming week. The computer-generated IBD 50 list of premier stocks is based on a combination of each company’s recent profit growth record, its IBD Composite Rating and its price performance over the last 12 months. Today’s IBD 50 list includes five top-rated tech-related stocks that are
Combining superior fundamentals with strong chart action can pinpoint top stock watch candidates such as Gilead Sciences. Today’s Screen Of The Day, Top Fundamentals, features highly rated firms with three-year sales and earnings growth rates of at least 25%, sorted by the biggest estimated earnings-per-share percentage change from a year ago. The list includes three companies that also have the stability of size: drugmaker Gilead Sciences (GILD),